Editorial: Computational drug discovery of medicinal compounds for cancer management, volume II

被引：1
|
作者：
Ahmad, Khurshid [1 ]
Shaikh, Sibhghatulla [1 ]
Khan, Faez Iqbal [2 ]
Khan, Mohammad Ehtisham [3 ]
机构：
[1] Yeungnam Univ, Dept Med Biotechnol, Gyongsan, South Korea
[2] Xian Jiaotong Liverpool Univ, Sch Sci, Dept Biol Sci, Suzhou, Jiangsu, Peoples R China
[3] Jazan Univ, Coll Appl Ind Technol, Dept Chem Engn Technol, Jazan, Saudi Arabia
来源：
FRONTIERS IN CHEMISTRY | 2024年 / 12卷
关键词：
computational methods; drug discovery; cancer; medicinal compounds; druglikeness; artificial intelligence;
D O I：
10.3389/fchem.2024.1446510
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
引用
收藏
页数：2
相关论文
共 45 条
  • [21] Strategies in Medicinal Chemistry to Discover New Hit Compounds against Ebola Virus: Challenges and Perspectives in Drug Discovery
    dos Santos Nascimento, Igor Jose
    da Silva Santos-Junior, Paulo Fernando
    de Araujo-Junior, Joao Xavier
    da Silva-Junior, Edeildo Ferreira
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2022, 22 (22) : 2896 - 2924
  • [22] Editorial: Computational Tools in Inferring Cancer Tissue-of-Origin and Molecular Classification Towards Personalized Cancer Therapy, Volume II
    Kui, Ling
    Mao, Wenzhe
    Majeed, Aasim
    Chen, Jian
    FRONTIERS IN GENETICS, 2021, 12
  • [23] Editorial: Advances in novel pharmacotherapeutics and drug discovery: computational, experimental, translational, and clinical models
    Sandoval, Cristian
    Torrens, Francisco
    Souza-Mello, Vanessa
    Farias, Jorge
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [24] Editorial: Computational and systematic analysis of multi-omics data for drug discovery and development
    Guo, Shicheng
    Zhang, Dake
    Wang, Hu
    An, Qin
    Yu, Guangchuang
    Han, Junwei
    Jiang, Chunjie
    Huang, Jianfeng
    FRONTIERS IN MEDICINE, 2023, 10
  • [25] Preclinical Drug Discovery in Colorectal Cancer: A Focus on Natural Compounds
    Rahman, Heshu Sulaiman
    CURRENT DRUG TARGETS, 2021, 22 (09) : 977 - 997
  • [26] Editorial: Natural products as drivers in drug development for neurodegenerative disorders, volume II
    Silva, Joana
    Alvarino, Rebeca
    Goettert, Marcia I.
    Caruncho, Hector J.
    Alves, Celso
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [27] Medicinal Potential of Heterocyclic Compounds from Diverse Natural Sources for the Management of Cancer
    Singh, Manjinder
    Sharma, Pratibha
    Singh, Pankaj Kumar
    Singh, Thakur Gurjeet
    Saini, Balraj
    MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2020, 20 (11) : 942 - 957
  • [28] Cisplatin and Procaterol Combination in Gastric Cancer? Targeting Checkpoint Kinase 1 for Cancer Drug Discovery and Repurposing by an Integrated Computational and Experimental Approach
    Giridhara Prema, Suchitha
    Chandrasekaran, Jaikanth
    Kanekar, Saptami
    George, Mejo
    Prasad, Thottethodi Subrahmanya Keshava
    Raju, Rajesh
    Dagamajalu, Shobha
    Balaya, Rex Devasahayam Arokia
    OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY, 2024, 28 (01) : 8 - 23
  • [29] Editorial: Application of systems biology in molecular characterization and diagnosis of cancer, Volume II
    Wei, Yongjun
    Zhang, Cheng
    Mardinoglu, Adil
    Zhang, Peng
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2022, 9
  • [30] Editorial: Targeted cancer therapies, from small molecules to antibodies, volume II
    Su, Chao-Yue
    Yan, Yan-Yan
    Zhang, Jian-Ye
    Zhang, Yun-Kai
    Chen, Zhe-Sheng
    FRONTIERS IN PHARMACOLOGY, 2023, 14
12345